(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--deCODE,genetics,In...ts,"firstday"motionsbytheU.S.BankruptcyCourtforthe...stweekfiledavoluntarypetitionfor,reliefunderChapte...cyCourt. , TheordersissuedbytheBankruptcyCour...ingtheChapter11proceedings.Inparticular,the,compan...
(Date:11/24/2009)...wswire-Asia/--ShanghaiBiolaxyannouncedthe,ChineseS...e,investigationalnewdrugapplication(IND)foritsoral...tiontotreatdiabetes.ThisIND,approvalallowsBiolaxyt...tesisadisordercharacteristicofhighbloodglucoseandp...ltinseveremicro-and,macro-vasculardiseases,lossofv...
(Date:11/24/2009)...inthasbeenmetforpatientswithadvanced-stage,orrecur...Newswire-FirstCall/-AEternaZentarisInc.(NASDAQ: AE...lcompanyfocusedonendocrinetherapyandoncology,today...tstargetedcytotoxicpeptideconjugate,AEZS-108(forme...trialcancer.Inapersonalizedhealthcareapproach,thes...
(Date:11/24/2009).../PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc.(...duledtopresentatthePiperJaffray21stAnnualHealthCar...8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewYo...eOfficer,isscheduledtoprovideanoverviewofthecompan...ams. ,, Aliveaudiowebcastofthepresentationwillb...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2...vide Testing for Important Cancer and Leukemia Gro...ROUGH, Mass., Dec. 4 Genzyme Genetics,a business ...unced today its,participation in a Cancer and Leuk...al Cancer Institute. The multi-center study will i... lymphocytic leukemia (CLL) and is,designed to tes...
...l Incorporated (Nasdaq:,VICL) announced today the ...tp://www.vical.com . The site includes information...pcoming webcasts, technology and product,overviews...e and management,information, and other data of in...s., About Vical, Vical researches and develops b...
...reliminary design review has concluded and verifie...the Optical Telescope Element on NASAs James Webb ...or OTE is the "eye" of the Webb Observatory. The t...ry mirror; secondary, tertiary and fine steering m...r and control electronics. , "The successful comp...
Other Biology Technology:National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 2National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 3National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment 4Vical Launches Redesigned Website 2James Webb Space Telescope marks successful completion 2...sh Neurotoxicity Research , the official journal ...d at neuroscience researchers and neurologists. , ...o our program," said Matthew Giampoala, Editor of ...ing together with the Neurotoxicity Society, we lo...utation as an essential source of knowledge on neu...
...offer new opportunities to explore how genes influ...lenge of analyzing huge amounts of genetic and cli...e Lausanne Branch of the international Ludwig Inst...ute of Bioinformatics (SIB) and the University Hos..., a computational tool that displays genetic diffe...
... have invented the world,s smallest version of the...ther micro-organisms from several sides at once. ,... only see cells from one side, the top," says team... biological sciences. "Not only can we see the top...hing biologists almost never see." , The research...
Other Biology News:New tool for genome-wide association studies 2Vanderbilt scientists invent world's smallest periscopes 2Vanderbilt scientists invent world's smallest periscopes 3GIBCO Advanced D-MEM (Dulbecco's Modified Eagle Medium) (1X) liquid from Invitrogen
TNT T7 Coupled Wheat Germ Extract System from Promega
GIBCO Modified Eagle Medium (MEM) (2X); liquid from Invitrogen
Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
Biology Products: